President Trump laments drug price measure will not improve midterm prospects

14 articles · Updated · The Washington Post · Apr 25

At an Oval Office event, Trump announced a drug price reduction measure but expressed doubt it would help Republicans in the November 2026 midterms.
Recent polls show voters now prefer Democrats on the economy for the first time since 2010, and many Republicans disapprove of Trump’s handling of inflation.
Trump faces mounting political challenges, including gerrymandering setbacks and issues related to Iran, further complicating his party’s outlook for the upcoming elections.

With two major federal programs now lowering drug prices, which one will have the biggest impact on consumers?

Could America's new drug price strategy inadvertently make medicines more expensive for the rest of the world?

As U.S. drug prices fall, could the pipeline for future life-saving cures be at risk?

With conflicting reports on drug prices, are Americans actually saving money on their prescriptions?

Beyond price cuts, is the government tackling the 'patent thickets' that keep cheaper generic drugs off the market?

New rules expose hidden pharmacy fees, but will patients actually see those savings in their own pockets?